Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment
| dc.authorid | 0000-0002-1240-7233 | |
| dc.contributor.author | Dayangaç, Murat | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T20:03:22Z | |
| dc.date.available | 10.07.201910:49:13 | |
| dc.date.available | 2019-07-10T20:03:22Z | |
| dc.date.issued | 2018 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalı | |
| dc.description | Joint International Congress of ILTS, ELITA and LICAGE -- MAY 23-26, 2018 -- Lisbon, PORTUGAL | |
| dc.description | WOS: 000436897700436 | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.description.sponsorship | International Liver Transplantation Society, European Liver and Intestine Transplant Association, Liver Intensive Care Group of Europe | en_US |
| dc.identifier.citation | Dayangaç, M. (2018). Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment. Joint International Congress of ILTS, ELITA and LICAGE içinde (213-213. ss.). Lisbon, Portugal, 23-26 May 2018. | |
| dc.identifier.endpage | 213 | |
| dc.identifier.issn | 0041-1337 | |
| dc.identifier.issn | 1534-6080 | |
| dc.identifier.issue | Supplement: 5 | |
| dc.identifier.startpage | 213 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/3860 | |
| dc.identifier.volume | 102 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.ispartof | Joint International Congress of ILTS, ELITA and LICAGE | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Reconversion | |
| dc.subject | Calcineurin | |
| dc.subject | Immunosuppression | |
| dc.subject | Recipients | |
| dc.title | Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment | |
| dc.type | Conference Object |











